Тези резултати са статистически значими (p < 0. 001) при сравнение с групата на плацебо, съответно 3% (6/ 179) и 2% (3/ 179).
These results were statistically significant (p < 0.001) by comparison with the vehicle group, 3% (6/179) and 2% (3/179) respectively.